• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Genetics help determine age at menarche

Article

Genetic effects explain about half the variation in age at menarche, and nonshared environmental factors account for the rest, according to a new study.

Genetic effects explain about half the variation in age at menarche, and nonshared environmental factors account for the rest, according to a study of related pairs of women with different combinations of shared genetic, environmental, and childhood factors.

British researchers examined familial concordance for age at menarche in 25,970 women who had at least 1 first- or second-degree relative also enrolled in the study. Participants included mother-daughter pairs, monozygotic twins, dizygotic twins, half-sisters, grandmother-granddaughter pairs, and aunt-niece pairs.

Heritability accounted for an estimated 57% of the variation in age at menarche in the study population. A woman's age at menarche was strongly related to that of her first-degree relatives. Associations for second-degree relatives were weaker.

Morris DH, Jones ME, Minouk MJ, Ashworth A, Swerdlow AJ. Familial concordance for age at menarche: analyses from the Breakthrough Generations Study. Paediatr Perinat Epidemiol. 2011;25(3):306-311.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.